Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Feb. 28 '26)

Image
By G.M.

 


    Arch Virol

  1. KOBAYASHI D, Hiono T, Adachi R, Igarashi M, et al
    Length and density of alpha2-3 sialyllactose-containing chains on glycopolymers determine receptor binding of avian influenza viruses.
    Arch Virol. 2026;171:100.
    PubMed        

  2. PARK SH, Lee SH, Seo YR, Kim DJ, et al
    Evolution and spread of H8Nx avian influenza viruses from wild birds in East Asia, 2019-2024.
    Arch Virol. 2026;171:95.
    PubMed         Abstract available

  3. NAVEED A
    The bovine mammary gland as a crucible for zoonotic influenza virus emergence: Receptor-mediated adaptation of HPAI H5N1 clade 2.3.4.4b.
    Arch Virol. 2026;171:89.
    PubMed        


    Biochem Biophys Res Commun

  4. SINGH VA, Nehul S, Saha A, Singh V, et al
    Bioengineered chimeric VLPs targeting chikungunya virus and SARS-CoV-2 show high immunogenicity in mice.
    Biochem Biophys Res Commun. 2026;805:153346.
    PubMed         Abstract available


    BMC Pediatr

  5. KARAKURT LT, Bozkurt HB, Uslu G, Bal F, et al
    Attitudes and behaviors of adolescents with asthma and their parents toward influenza and COVID-19 vaccination: barriers and facilitators of uptake.
    BMC Pediatr. 2026 Feb 26. doi: 10.1186/s12887-026-06575.
    PubMed        


    BMJ

  6. VANDVIK PO, Agarwal A, Rylance J, Agoritsas T, et al
    Summary of WHO clinical practice guidelines for influenza.
    BMJ. 2026;392:e087397.
    PubMed         Abstract available


    Drug Saf

  7. MORGAN HJ, Bloomfield L, Clothier HJ, Ngeh S, et al
    Statistical Methods for Multi-jurisdictional Australian Vaccine Safety Investigations of Rare Adverse Events.
    Drug Saf. 2026;49:353-365.
    PubMed         Abstract available


    Epidemiol Infect

  8. UNNIKRISHANAN R, Zhao Y, Burgess CP, Markey PG, et al
    Measuring the excess mortality during the COVID-19 pandemic in the Northern Territory, Australia.
    Epidemiol Infect. 2026;154:e26.
    PubMed         Abstract available


    J Gen Virol

  9. FARRELL ML, McGrath G, Cuartero LG, Barry G, et al
    Avian influenza in Ireland: a spatiotemporal, subtype and host-based analysis (1983-2024).
    J Gen Virol. 2026;107:002218.
    PubMed         Abstract available


    J Immunol

  10. APPS R, Polanco JJ, Lowman KE, Wang L, et al
    Leveraging optimized oligonucleotide-tagged antigen assemblies and single-cell sequencing for multiplexed proteogenomic profiling of human B cell reactivities.
    J Immunol. 2026;215:vkaf301.
    PubMed         Abstract available

  11. LOPEZ ZAPANA PA, Shook LL, Joughin BA, Jasset OJ, et al
    Maternal proteome profiling reveals dynamic gestational age-specific responses to de novo vaccination.
    J Immunol. 2025 Dec 12:vkaf298. doi: 10.1093.
    PubMed         Abstract available

  12. CONDE L, Oliveira DL, Maciel G, Castro F, et al
    Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery.
    J Immunol. 2026;215:vkaf305.
    PubMed         Abstract available


    J Infect

  13. ORDONEZ-MENA JM, Radin JM, Hoang U, Araujo AB, et al
    Epidemiology of virologically confirmed RSV, influenza and COVID-19 in adults in England, 2023-2024: Primary Care Observational Study of Acute Respiratory Infection (ObservatARI).
    J Infect. 2026 Feb 21:106714. doi: 10.1016/j.jinf.2026.106714.
    PubMed         Abstract available


    PLoS One

  14. N'DIAYE A, Garrett C, Wilcox S, Olatosi B, et al
    Challenges, stressors, and resilience resources experienced by older black women in Rural South Carolina throughout the COVID-19 pandemic.
    PLoS One. 2026;21:e0342512.
    PubMed         Abstract available

  15. SEIBERT FS, Kurucay M, Wiemers L, Stervbo U, et al
    Association of G-Protein-Coupled Receptors autoantibodies with vasoregulation in Post-COVID.
    PLoS One. 2026;21:e0343264.
    PubMed         Abstract available

  16. BAYARAA O, Ganbold C, Byambadorj B, Battulga Z, et al
    The synergistic interaction between ACE and TMPRSS2 polymorphisms increases the risk of severe COVID-19.
    PLoS One. 2026;21:e0343590.
    PubMed         Abstract available

  17. KHEZRI R, Ebrahimi K, Askari S, Jahanfar S, et al
    Maternal and neonatal outcomes following SARS-CoV-2 infection in an unvaccinated pregnant cohort: A trimester-specific analysis.
    PLoS One. 2026;21:e0341647.
    PubMed         Abstract available

  18. FINKELSTEIN A, Genut S, Golos A
    Experiences of women with disabilities during and after COVID-19: Needs, sources of support and implications for policy and practice.
    PLoS One. 2026;21:e0342900.
    PubMed         Abstract available

  19. ELGNER M, Binnebose M, Grossmann J, Frank T, et al
    How to cope with Long COVID - A qualitative interview study on stressors and coping strategies of people affected by long-term consequences of COVID-19.
    PLoS One. 2026;21:e0343115.
    PubMed         Abstract available

  20. PIN C, Taylor S, Ferreira C, Arnetorp S, et al
    A dynamic model of COVID-19 infection quantifies the impact of preventive interventions on the infection of severely immunocompromised subjects in the United Kingdom.
    PLoS One. 2026;21:e0341331.
    PubMed         Abstract available


    Vaccine

  21. PEREDO R, Savard N, Separovic L, Zhan Y, et al
    Influenza vaccination status ascertainment and vaccine effectiveness estimation: Validity of self-report for current and prior season.
    Vaccine. 2026;77:128368.
    PubMed         Abstract available


    Virology

  22. LOPEZ-LOPEZ N, Mejia-Torres M, Diaz-Caldera MA, Martinez-Castilla AM, et al
    Sequential infection with rhinovirus followed by Influenza Virus led to an increased antiviral response in A549 cells.
    Virology. 2026;618:110847.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »